I
Insilico Medicine is an AI-driven drug discovery company that uses generative AI to design novel drug molecules, identify disease targets, and predict clinical trial outcomes, with a pipeline spanning oncology, fibrosis, and immunology. It has demonstrated industry-leading speed in generating clinical candidates from concept to IND.
Category
Healthcare
Subcategory
Drug Discovery
// ACCESS METHODS
Web App
// COMPLIANCE
○SOC2○ISO27001○GDPR○HIPAA
● certified · ○ not verified
// DATA STORAGE
Region
—
Trains on Data
—
Self-hostable
No
// PRICING DETAIL
Free Tier
Not available yet
Paid Plans
Pharma partnerships and Pharma.AI platform licensing
API Cost
Not available yet
// MORE IN DRUG DISCOVERY
R
Recursion PharmaceuticalsHealthcareDrug Discovery
#drug discovery#machine learning#biology
A
AtomwiseHealthcareDrug Discovery
#drug discovery#molecular modeling#deep learning
B
BenevolentAIHealthcareDrug Discovery
#drug discovery#knowledge graph#biomedical ai
// USE CASES
Designing novel small molecule drug candidates with generative AIIdentifying new biological targets for disease treatmentPredicting potential drug candidates for IPF and oncologyAccelerating hit-to-lead optimization in drug discoveryPharmaceutical R&D partnerships for target-specific programs